Search results
FDA panel rejects MDMA-based treatment for PTSD
The Hill· 3 hours agoThe Food and Drug Administration (FDA) panel voted 10-1 against endorsing the safety of MDMA in treating PTSD, and 9-2 against its efficacy. The FDA is...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 14 hours agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA Panel Rejects MDMA Treatment
newser· 15 minutes agoHistoric: FDA advisers have never before considered a Schedule I psychedelic drug for medical use. In addition, no new treatment for PTSD has been approved in more than 20 ...
FDA advisers vote against recommending approval of MDMA as treatment for PTSD
ABC News· 8 hours agoA panel of independent advisers for the U.S. Food and Drug Administration voted against recommending...
FDA advisers vote against first MDMA therapy to treat PTSD
CNN via Yahoo News· 7 hours agoA federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly...
FDA panel rejects psychedelic drug MDMA as a PTSD treatment - The Boston Globe
The Boston Globe· 5 hours agoThe FDA is not required to follow the group’s advice and is expected to make its final decision by...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
NBC News via Yahoo News· 6 hours agoA Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA,...
FDA Warns Recalled Cookie Dough Company Over “Serious Violations”
IFLScience· 15 hours agoAfter one of its cookie dough products was taken off shelves last year following the discovery it...
FDA advisory panel votes against allowing MDMA as PTSD treatment
United Press International via Yahoo News· 5 hours agoThe popular underground drug midomafetamine, also called MDMA and "ecstasy," failed to win an...
FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns
BioPharma Dive via Yahoo Finance· 12 hours agoA group of independent experts wasn't convinced by clinical trial data from company Lykos...
